Intracellular Th Stock EBITDA
ITCI Stock | USD 72.37 0.37 0.51% |
Intracellular Th fundamentals help investors to digest information that contributes to Intracellular's financial success or failures. It also enables traders to predict the movement of Intracellular Stock. The fundamental analysis module provides a way to measure Intracellular's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Intracellular stock.
Last Reported | Projected for Next Year | ||
EBITDA | -158.9 M | -166.8 M |
Intracellular | EBITDA |
Intracellular Th Company EBITDA Analysis
Intracellular's EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Current Intracellular EBITDA | (158.85 M) |
Most of Intracellular's fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Intracellular Th is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Intracellular EBITDA Driver Correlations
Understanding the fundamental principles of building solid financial models for Intracellular is extremely important. It helps to project a fair market value of Intracellular Stock properly, considering its historical fundamentals such as EBITDA. Since Intracellular's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Intracellular's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Intracellular's interrelated accounts and indicators.
Click cells to compare fundamentals
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
Competition |
Intracellular Ebitda
Ebitda |
|
According to the company disclosure, Intracellular Th reported earnings before interest,tax, depreciation and amortization of (158.85 Million). This is 118.1% lower than that of the Pharmaceuticals sector and significantly lower than that of the Health Care industry. The ebitda for all United States stocks is 104.07% higher than that of the company.
Intracellular EBITDA Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Intracellular's direct or indirect competition against its EBITDA to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Intracellular could also be used in its relative valuation, which is a method of valuing Intracellular by comparing valuation metrics of similar companies.Intracellular is currently under evaluation in ebitda category among related companies.
Intracellular Current Valuation Drivers
We derive many important indicators used in calculating different scores of Intracellular from analyzing Intracellular's financial statements. These drivers represent accounts that assess Intracellular's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Intracellular's important valuation drivers and their relationship over time.
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Market Cap | 623.1M | 1.9B | 4.3B | 5.0B | 6.9B | 7.2B | |
Enterprise Value | 568.2M | 1.8B | 4.2B | 4.8B | 6.7B | 7.1B |
Intracellular Institutional Holders
Institutional Holdings refers to the ownership stake in Intracellular that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Intracellular's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Intracellular's value.Shares | Alliancebernstein L.p. | 2023-12-31 | 1.8 M | Franklin Resources Inc | 2023-12-31 | 1.8 M | Wellington Management Company Llp | 2023-12-31 | 1.8 M | Gw&k Investment Management, Llc | 2023-12-31 | 1.6 M | Macquarie Group Ltd | 2023-12-31 | 1.6 M | Clearbridge Advisors, Llc | 2023-12-31 | 1.6 M | Holocene Advisors, Lp | 2023-09-30 | 1.4 M | Pictet Asset Manangement Sa | 2023-12-31 | 1.3 M | T. Rowe Price Associates, Inc. | 2023-12-31 | 1.3 M | Fmr Inc | 2023-12-31 | 11.5 M | Vanguard Group Inc | 2023-12-31 | 9.1 M |
Intracellular Fundamentals
Return On Equity | -0.22 | ||||
Return On Asset | -0.13 | ||||
Profit Margin | (0.30) % | ||||
Operating Margin | (0.26) % | ||||
Current Valuation | 6.49 B | ||||
Shares Outstanding | 97.48 M | ||||
Shares Owned By Insiders | 2.49 % | ||||
Shares Owned By Institutions | 98.36 % | ||||
Number Of Shares Shorted | 3.47 M | ||||
Price To Earning | (6.56) X | ||||
Price To Book | 10.78 X | ||||
Price To Sales | 13.73 X | ||||
Revenue | 462.18 M | ||||
Gross Profit | 95.16 M | ||||
EBITDA | (158.85 M) | ||||
Net Income | (139.67 M) | ||||
Cash And Equivalents | 628.74 M | ||||
Cash Per Share | 6.64 X | ||||
Total Debt | 16.94 M | ||||
Debt To Equity | 0.04 % | ||||
Current Ratio | 9.81 X | ||||
Book Value Per Share | 6.14 X | ||||
Cash Flow From Operations | (124.2 M) | ||||
Short Ratio | 5.29 X | ||||
Earnings Per Share | (1.46) X | ||||
Target Price | 89.71 | ||||
Number Of Employees | 610 | ||||
Beta | 1.01 | ||||
Market Capitalization | 7.02 B | ||||
Total Asset | 728.29 M | ||||
Retained Earnings | (1.62 B) | ||||
Working Capital | 544.25 M | ||||
Current Asset | 541.82 M | ||||
Current Liabilities | 140.69 M | ||||
Net Asset | 728.29 M |
About Intracellular Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Intracellular Th's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Intracellular using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Intracellular Th based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Intracellular Investors Sentiment
The influence of Intracellular's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Intracellular. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Intracellular's public news can be used to forecast risks associated with an investment in Intracellular. The trend in average sentiment can be used to explain how an investor holding Intracellular can time the market purely based on public headlines and social activities around Intracellular Th. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Intracellular's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Intracellular's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Intracellular's news discussions. The higher the estimated score, the more favorable is the investor's outlook on Intracellular.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Intracellular in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Intracellular's short interest history, or implied volatility extrapolated from Intracellular options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Intracellular Piotroski F Score and Intracellular Altman Z Score analysis. Note that the Intracellular Th information on this page should be used as a complementary analysis to other Intracellular's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Complementary Tools for Intracellular Stock analysis
When running Intracellular's price analysis, check to measure Intracellular's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Intracellular is operating at the current time. Most of Intracellular's value examination focuses on studying past and present price action to predict the probability of Intracellular's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Intracellular's price. Additionally, you may evaluate how the addition of Intracellular to your portfolios can decrease your overall portfolio volatility.
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |
Is Intracellular's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Intracellular. If investors know Intracellular will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Intracellular listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.46) | Revenue Per Share 4.843 | Quarterly Revenue Growth 0.503 | Return On Assets (0.13) | Return On Equity (0.22) |
The market value of Intracellular Th is measured differently than its book value, which is the value of Intracellular that is recorded on the company's balance sheet. Investors also form their own opinion of Intracellular's value that differs from its market value or its book value, called intrinsic value, which is Intracellular's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Intracellular's market value can be influenced by many factors that don't directly affect Intracellular's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Intracellular's value and its price as these two are different measures arrived at by different means. Investors typically determine if Intracellular is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Intracellular's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.